DK2338476T3 - Suppositorium til rektal, vaginal eller urethral indgivelse indeholdende et probiotikum, et antibiotikum og en umættet ikke-forestret fedtsyre - Google Patents

Suppositorium til rektal, vaginal eller urethral indgivelse indeholdende et probiotikum, et antibiotikum og en umættet ikke-forestret fedtsyre

Info

Publication number
DK2338476T3
DK2338476T3 DK09014964.2T DK09014964T DK2338476T3 DK 2338476 T3 DK2338476 T3 DK 2338476T3 DK 09014964 T DK09014964 T DK 09014964T DK 2338476 T3 DK2338476 T3 DK 2338476T3
Authority
DK
Denmark
Prior art keywords
probiotic
suppository
vaginal
rectal
antibiotic
Prior art date
Application number
DK09014964.2T
Other languages
English (en)
Inventor
Bettina Heil
Original Assignee
Bettina Heil
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bettina Heil filed Critical Bettina Heil
Application granted granted Critical
Publication of DK2338476T3 publication Critical patent/DK2338476T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Reproductive Health (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK09014964.2T 2009-12-02 2009-12-02 Suppositorium til rektal, vaginal eller urethral indgivelse indeholdende et probiotikum, et antibiotikum og en umættet ikke-forestret fedtsyre DK2338476T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09014964A EP2338476B1 (en) 2009-12-02 2009-12-02 Suppository for rectal, vaginal or urethral administration containing a probiotic, an antibiotic and an unsaturated non-esterified fatty acid

Publications (1)

Publication Number Publication Date
DK2338476T3 true DK2338476T3 (da) 2012-09-17

Family

ID=41810070

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09014964.2T DK2338476T3 (da) 2009-12-02 2009-12-02 Suppositorium til rektal, vaginal eller urethral indgivelse indeholdende et probiotikum, et antibiotikum og en umættet ikke-forestret fedtsyre

Country Status (10)

Country Link
US (1) US20120237489A1 (da)
EP (2) EP2338476B1 (da)
JP (1) JP2013512863A (da)
CN (1) CN102753142A (da)
BR (1) BR112012012960A2 (da)
CA (1) CA2782204A1 (da)
DK (1) DK2338476T3 (da)
ES (1) ES2388478T3 (da)
PT (1) PT2338476E (da)
WO (1) WO2011066949A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2992861B1 (fr) 2012-07-09 2014-10-17 Probionov Utilisation de thiosulfate pour potentialiser l'effet anti-pathogene des lactobacilles
CN104434999A (zh) * 2014-11-07 2015-03-25 南昌大学 一种治疗妇女炎症的益生菌栓塞和胶囊的制备方法
CA2985729C (en) 2015-05-11 2023-05-09 Mybiotics Pharma Ltd Systems and methods for growing a biofilm of probiotic bacteria on solid particles for colonization of bacteria in the gut
FR3050641B1 (fr) * 2016-04-27 2018-04-13 Biocodex Composition utile pour la preparation d’un ovule
AU2017271491A1 (en) 2016-05-25 2018-12-13 Mybiotics Pharma Ltd. Composition and methods for microbiota therapy
CA3060243A1 (en) 2017-04-17 2018-10-25 The University Of Chicago Polymer materials for delivery of short-chain fatty acids to the intestine for applications in human health and treatment of disease
WO2018213751A1 (en) * 2017-05-19 2018-11-22 Lunella Biotech, Inc. Antimitoscins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells
CN108653729B (zh) * 2018-08-27 2021-11-19 广州汇高生物科技有限公司 一种***泡沫剂及其应用
CN109010825B (zh) * 2018-08-27 2021-11-19 广州汇高生物科技有限公司 一种***原位凝胶制剂及其制备方法和应用
CN108853475B (zh) * 2018-09-29 2021-06-18 沈阳师范大学 一种酸化肠道抑菌栓剂及其制备方法
US10709744B1 (en) * 2019-03-28 2020-07-14 Mybiotics Pharma Ltd. Probiotic biofilm suppositories
US20220154134A1 (en) * 2019-03-28 2022-05-19 Mybiotics Pharma Ltd. Probiotic biofilm compositions and methods of preparing same
WO2022190004A1 (en) * 2021-03-10 2022-09-15 Superbrewed Food, Inc. Antibiotic-resistant probiotics and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
JPS58140026A (ja) * 1982-01-14 1983-08-19 Toyo Jozo Co Ltd 吸収性良好な製剤
US5733568A (en) * 1993-12-03 1998-03-31 Lafor Laboratories Limited Micro-encapsulated lactobacilli for medical applications
US8828432B2 (en) * 1996-10-28 2014-09-09 General Mills, Inc. Embedding and encapsulation of sensitive components into a matrix to obtain discrete controlled release particles
US6172040B1 (en) * 1999-05-28 2001-01-09 A. Satyanarayan Naidu Immobilized lactoferrin antimicrobial agents and the use thereof
ATE270558T1 (de) * 1999-08-26 2004-07-15 Ganeden Biotech Inc Verwendung von emu-öl als träger für fungizide, antibakterielle und antivirale arzneien
AU2003303894A1 (en) * 2003-01-30 2004-08-30 The Regents Of The University Of California Inactivated probiotic bacteria and methods of use thereof
ATE289514T1 (de) * 2003-11-03 2005-03-15 Peter-Hansen Volkmann Vaginalpflegezusammensetzung
US20050214364A1 (en) * 2004-03-23 2005-09-29 Hutman Herbert W Products and methods for treating vaginal infections
RU2006140784A (ru) * 2004-04-20 2008-05-27 Дзе Юниверсити Оф Чикаго (Us) Терапевтическая система доставки, содержащая высокомолекулярное пэг-подобное соединение
US20060078616A1 (en) * 2004-08-30 2006-04-13 Georgewill Dawaye A Thermoreversible pharmaceutical formulation for anti-microbial agents comprising poloxamer polymers and hydroxy fatty acid ester of polyethylene glycol
EP1791544A4 (en) * 2004-09-08 2007-09-12 Chelsea Therapeutics Inc DERIVATIVES OF QUINAZOLIN AS METABOLICALLY INERT ANTIFOLIC
US20090253634A1 (en) * 2005-08-19 2009-10-08 Microbia, Inc. Methods and Compositions for the Treatment of Gastrointestinal Disorders
US20090192083A1 (en) * 2006-02-24 2009-07-30 Currie Mark G Methods and compositions for the treatment of gastrointestinal disorders

Also Published As

Publication number Publication date
ES2388478T3 (es) 2012-10-15
EP2338476A1 (en) 2011-06-29
US20120237489A1 (en) 2012-09-20
EP2338476B1 (en) 2012-06-20
CA2782204A1 (en) 2011-06-09
EP2505188A1 (en) 2012-10-03
BR112012012960A2 (pt) 2018-05-22
JP2013512863A (ja) 2013-04-18
CN102753142A (zh) 2012-10-24
PT2338476E (pt) 2012-09-28
WO2011066949A1 (en) 2011-06-09

Similar Documents

Publication Publication Date Title
DK2338476T3 (da) Suppositorium til rektal, vaginal eller urethral indgivelse indeholdende et probiotikum, et antibiotikum og en umættet ikke-forestret fedtsyre
ZA201109493B (en) Stem accelerated isothermal nucleic acid amplification technology
HK1190212A1 (zh) 用於操縱軟鍵盤的設備、方法和計算機可讀介質
EP2477695A4 (en) DEVICE AND METHODS FOR VAGINAL REMODELING
BRPI1010926A2 (pt) fórmulas para alimentação infantil compreendendo micro-organismos probióticos.
BRPI0912106A2 (pt) probióticos para melhorar a microbiota intestinal
BRPI1015164A2 (pt) método e sistema para gerar automaticamente conteúdo específico de localização para uma entidade particular, e, método e sistema para fornecer conteúdo específico de localização para uma entidade particular tendo uma pluralidade de localizações físicas
EP2476070A4 (en) METHOD AND DEVICE FOR SELECTIVELY COMMON USE OF SEMANTIC INFORMATION RATES
GB0701253D0 (en) Nucleic acid amplification and testing
FI20095550A0 (fi) Vaginaalinen antojärjestelmä
HK1150857A1 (en) Microrna (mirna) mir-21 for diagnostic and therapeutic purposes
FI20096288A0 (fi) Formulations and methods for culturing stem cells
DK3530740T3 (da) Thraustochytrider, fedtsyresammensætninger og fremgangsmåder til fremstilling deraf og anvendelser deraf
SI2306973T1 (sl) Vaginalni supozitorij, obsegajoč mlečno kislino
ZA201303648B (en) Novel fatty acid desaturases, elongases, elongation components and uses thereof
AU2014203841B2 (en) Methods and reagents for efficient and targeted gene transfer to monocytes and macrophages
EP2511169A4 (en) UNIVERSAL FLOAT AND LAUNCH SYSTEM AND METHOD OF OPERATION
BRPI1007701A2 (pt) dispositivo e método para o tratamento de incontinência urinária feminina e kit contendo uma pluralidade de dispositivos
PL2506825T3 (pl) Enzymy z płynu z wyklucia i ich zastosowania
PL2542658T3 (pl) Sposób i urządzenie do fermentacji anaerobowej
EP2438184A4 (en) METHOD FOR AMPLIFYING NUCLEIC ACIDS
GB0909420D0 (en) Device for nucleic acid amplification
BRPI0924507A2 (pt) método para implementar uma realocação entre redes e sistema para implementar uma realocação entre redes.
FI20095563A (fi) Vaginaalinen antojärjestelmä
GB2470997B (en) Pipe plugging system and method